Abstract:We report on using the synthetic aminoadamantane-CH2-aryl derivatives 1–6 as sensitive probes for blocking M2 S31N and influenza A virus (IAV) M2 wild-type (WT) channels as well as virus replication in cell culture. The binding kinetics measured using electrophysiology (EP) for M2 S31N channel are very dependent on the length between the adamantane moiety and the first ring of the aryl headgroup realized in 2 and 3 and the girth and length of the adamantane adduct realized in 4 and 5. Study of 1–6 shows that, according to molecular dynamics (MD) simulations and molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) calculations, all bind in the M2 S31N channel with the adamantyl group positioned between V27 and G34 and the aryl group projecting out of the channel with the phenyl (or isoxazole in 6) embedded in the V27 cluster. In this outward binding configuration, an elongation of the ligand by only one methylene in rimantadine 2 or using diamantane or triamantane instead of adamantane in 4 and 5, respectively, causes incomplete entry and facilitates exit, abolishing effective block compared to the amantadine derivatives 1 and 6. In the active M2 S31N blockers 1 and 6, the phenyl and isoxazolyl head groups achieve a deeper binding position and high kon/low koff and high kon/high koff rate constants, compared to inactive 2–5, which have much lower kon and higher koff. Compounds 1–5 block the M2 WT channel by binding in the longer area from V27–H37, in the inward orientation, with high kon and low koff rate constants. Infection of cell cultures by influenza virus containing M2 WT or M2 S31N is inhibited by 1–5 or 1–4 and 6, respectively. While 1 and 6 block infection through the M2 block mechanism in the S31N variant, 2–4 may block M2 S31N virus replication in cell culture through the lysosomotropic effect, just as chloroquine is thought to inhibit SARS-CoV-2 infection.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00553?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00553</a>.Methods (for electrophysiology, anti-viral testing, simulations, and synthetic procedures including the characterization of compounds 1−5), EP results for 1 against the S31 channels of A/Calif/07/2009 M2 N31S and A/Udorn/72 M2 WT, RMSDs from MD simulations, molecular docking and MM-PBSA, SMD calculation results (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00553/suppl_file/cb0c00553_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Front Cover: Optimization of Ketobenzothiazole‐Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus Replication (ChemMedChem 2/2024)

Front Cover: A Study of the Activity of Adamantyl Amines against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple Blocker, Explored by Molecular Dynamics Simulations and Solid‐State NMR (ChemMedChem 16/2023)

Virtual Screening and Molecular Growth Guide the Design of Inhibitors for the Influenza Virus Drug-Resistant Mutant M2-V27A/S31N.

Residue-based Design of Small Molecule Inhibitor for H1N1, H5N1 and H7N1 Mutants

Structural Basis for the Inhibition of Coronaviral Main Proteases by a Benzothiazole-Based Inhibitor

Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.

Quantum biochemistry, molecular docking, and dynamics simulation revealed synthetic peptides induced conformational changes affecting the topology of the catalytic site of SARS-CoV-2 main protease

Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2

Design and synthesis of pinane oxime derivatives as novel anti-influenza agents

The Complexity of Molecular Interactions and Bindings between Cyclic Peptide and Inhibit Polymerase A and B1 (PAC-PB1N) H1N1

Design, Synthesis, and Unprecedented Interactions of Covalent Dipeptide-Based Inhibitors of SARS-CoV-2 Main Protease and its Variants Displaying Potent Antiviral Activity

Optimization of N-Substituted Oseltamivir Derivatives As Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.

Molecular Dynamics Analysis of Potent Inhibitors of M2 Proton Channel Against H1N1 Swine Influenza Virus

Synthesis, Molecular Docking, and Dynamic Simulation Targeting Main Protease (Mpro) of New, Thiazole Clubbed Pyridine Scaffolds as Potential COVID-19 Inhibitors

PK/PD investigation of antiviral host matriptase/TMPRSS2 inhibitors in cell models

Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors

Chemical Probes for Blocking of Influenza A M2 Wild-type and S31N Channels

Synthesis and Structure-Activity Optimization of 7-Azaindoles Containing Aza-Β-amino Acids Targeting the Influenza PB2 Subunit.

Design, Synthesis and Biological Evaluation of "Multi-Site"-binding Influenza Virus Neuraminidase Inhibitors.

Design of novel and highly selective SARS-CoV-2 main protease inhibitors

A Novel N-heterocycles Substituted Oseltamivir Derivatives As Potent Inhibitors of Influenza Virus Neuraminidase: Discovery, Synthesis and Biological Evaluation